Log In
BCIQ
Print this Print this
 

methylphenidate HCl extended-release capsules (Equasym XL)

Also known as: Metadate CD

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionPure chiral d-enantiomer of methylphenidate
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation
PartnerShire plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$70.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/23/2009

Undisclosed

$70.1M

Undisclosed

Get a free BioCentury trial today